These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2258679)

  • 21. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney.
    Bernátová I; Pechánová O; Simko F
    Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
    Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
    Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
    Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
    [No Abstract]   [Full Text] [Related]  

  • 24. [Angiotensin converting enzyme--captopril].
    Kaneko Y; Shionoiri H; Uneda S; Fujishima S
    Nihon Rinsho; 1979 Oct; 37(10):3492-8. PubMed ID: 392136
    [No Abstract]   [Full Text] [Related]  

  • 25. [Captopril and other angiotensin converting enzyme inhibitors in the treatment of hypertension].
    Hradec J
    Vnitr Lek; 1995 May; 41(5):336-9. PubMed ID: 7653065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dilated cardiomyopathy : clinical profile and treatment.
    Khalil A; Chawla K; Chakravarti A
    Indian Pediatr; 2000 Nov; 37(11):1242-6. PubMed ID: 11086307
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness and tolerance of benazepril versus captopril in patients with hypertension].
    Ol'binskaia LI; Golubev SA; Morozova TE
    Klin Med (Mosk); 1995; 73(5):36-8. PubMed ID: 8815273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Morphological and enzymatic adaptation of skeletal muscle fibers in stroke-prone hypertensive rats to ACE inhibitors].
    Ogoh S; Tsuda K; Taguchi S
    Nihon Seirigaku Zasshi; 1999; 61(7-8):295-304. PubMed ID: 10524265
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of angiotensin-converting enzyme: therapeutic implications.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
    [No Abstract]   [Full Text] [Related]  

  • 31. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACE Inhibitor in the treatment of cutaneous and lymphatic sarcoidosis.
    Kaura V; Kaura SH; Kaura CS
    Am J Clin Dermatol; 2007; 8(3):183-6. PubMed ID: 17492847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TCM treatment of hypertrophic cardiomyopaphy--a case report.
    Wang H; Yuan L
    J Tradit Chin Med; 2002 Sep; 22(3):170-3. PubMed ID: 12400417
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of captopril on sugar metabolism in hypertensive patients].
    Li YF
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Oct; 20(5):290-1. PubMed ID: 1306820
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of inhibitor of angiotensin-converting enzyme on uric acid metabolism].
    Hosoya T; Kono H; Ikeda H; Ichida K; Miyahara T
    Nihon Jinzo Gakkai Shi; 1987 Oct; 29(10):1271-80. PubMed ID: 3326955
    [No Abstract]   [Full Text] [Related]  

  • 36. Symposium on converting enzyme inhibition in hypertension.
    Med J Aust; 1979 Oct; 2(SP2):iii-xl. PubMed ID: 233755
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of captopril effect in congestive cardiomyopathy by a computerized noninvasive method.
    Simonyi J; Tél K; Istvánffy M; Cserhalmi L
    Acta Cardiol; 1988; 43(3):341-3. PubMed ID: 3041716
    [No Abstract]   [Full Text] [Related]  

  • 38. Captopril and blood glucose.
    Winocour P; Waldek S; Anderson DC
    Lancet; 1986 Aug; 2(8504):461. PubMed ID: 2874445
    [No Abstract]   [Full Text] [Related]  

  • 39. [ACE kininase inhibitor].
    Nagano M
    Nihon Naika Gakkai Zasshi; 1990 Sep; 79(9):1320-8. PubMed ID: 2258679
    [No Abstract]   [Full Text] [Related]  

  • 40. Potential of garlic and its active constituent, S-allyl cysteine, as antihypertensive and cardioprotective in presence of captopril.
    Asdaq SM; Inamdar MN
    Phytomedicine; 2010 Nov; 17(13):1016-26. PubMed ID: 20739164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.